Annals of Gastroenterological SurgeryThe incidence of upper‐third gastric cancer is rising, necessitating proximal gastrectomy or total gastrectomy in most patients. However, surgical removal of the fornix, a major site for ghrelin secretion, often results in reduced appetite and weight ...
Kohei Fujita +4 more
doaj +1 more source
Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report
Surgical Case Reports, 2018 Background Mixed adenoneuroendocrine carcinoma (MANEC) is a tumor of the gastrointestinal tract that contains both exocrine and endocrine components, with each component exceeding 30% of the total tumor area.
Miho Yamamoto +7 more
doaj +1 more source
Fundoplication in Patients with Esophageal Atresia : Patient Selection, Indications, and Outcomes [PDF]
, 2017 Patients with esophageal atresia (EA) suffer from abnormal and permanent esophageal intrinsic and extrinsic innervation that affects severely esophageal motility.
Bansal +44 more
core +1 more source
Fibrin sealant for the prevention of anastomotic leakage after esophagectomy for esophageal or esophagogastric junction cancer: interim report of a prospective, phase III, randomized controlled study [PDF]
, 2023 Ze-Rui Zhao +8 more
openalex +1 more source
Correlation between methylation of the caveolin‐1 gene and of caveolin‐1 messenger ribonucleic acid, and protein levels and human epidermal growth factor receptor 2 protein expression in adenocarcinomas of the esophagogastric junction [PDF]
, 2019 Ruizhen Liu +4 more
openalex +1 more source
Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
Open Medicine, 2016 The TGF-β/SMAD signaling pathway is found to play pivotal roles in cell growth, differentiation and tumorigenesis. Its target genes are closely related to the biological behaviors of some malignancies.
Peng Defeng, Fu Lin, Sun Guoping
doaj +1 more source
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis [PDF]
, 2017 The traditional endpoint for assessing efficacy of chemotherapies for advanced/recurrent gastric cancer is overall survival (OS), but OS requires prolonged follow-up.
Bang, Yung-Jue +22 more
core